litlas
ログインアカウント作成

Wei Mu

1989–2026 年に発表

216
論文数
18,439
被引用数
78
h 指数
175
i10 指数

被引用数

Wei Mu の年別被引用数1967 年: 被引用 1 件1991 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 12 件1997 年: 被引用 30 件1998 年: 被引用 43 件1999 年: 被引用 20 件2000 年: 被引用 76 件2001 年: 被引用 67 件2002 年: 被引用 80 件2003 年: 被引用 126 件2004 年: 被引用 84 件2005 年: 被引用 113 件2006 年: 被引用 78 件2007 年: 被引用 91 件2008 年: 被引用 100 件2009 年: 被引用 114 件2010 年: 被引用 136 件2011 年: 被引用 138 件2012 年: 被引用 111 件2013 年: 被引用 115 件2014 年: 被引用 107 件2015 年: 被引用 109 件2016 年: 被引用 93 件2017 年: 被引用 127 件2018 年: 被引用 92 件2019 年: 被引用 365 件2020 年: 被引用 519 件2021 年: 被引用 669 件2022 年: 被引用 672 件2023 年: 被引用 642 件2024 年: 被引用 1,078 件2025 年: 被引用 835 件2026 年: 被引用 167 件1968〜1990 年は被引用が無いため表示していません1992〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,076 件、この内訳の 25.2%アメリカ合衆国: 引用元論文 1,636 件、この内訳の 19.8%ドイツ: 引用元論文 332 件、この内訳の 4%イギリス: 引用元論文 325 件、この内訳の 3.9%イタリア: 引用元論文 301 件、この内訳の 3.7%オーストラリア: 引用元論文 270 件、この内訳の 3.3%日本: 引用元論文 267 件、この内訳の 3.2%インド: 引用元論文 198 件、この内訳の 2.4%韓国: 引用元論文 192 件、この内訳の 2.3%フランス: 引用元論文 186 件、この内訳の 2.3%カナダ: 引用元論文 171 件、この内訳の 2.1%スペイン: 引用元論文 146 件、この内訳の 1.8%
0%25.2%その他 26%

機関

分野

  • Medicine55.2%
  • Biochemistry, Genetics and Molecular Biology18.5%
  • Computer Science6.9%
  • Immunology and Microbiology5.8%
  • Engineering3.2%
  • Agricultural and Biological Sciences3.1%
  • その他7.3%

トピック

  • Radiomics and Machine Learning in Medical Imaging4.2%
  • Gout, Hyperuricemia, Uric Acid2.7%
  • CAR-T cell therapy research2.6%
  • Chronic Kidney Disease and Diabetes2.4%
  • Extracellular vesicles in disease1.8%
  • AI in cancer detection1.6%
  • その他84.7%

共著者

全論文

検索で開く
  1. Large-Scale Domain-Specific Pretraining for Biomedical Vision-Language Processing

    著者: Sheng Zhang, Yanbo Xu, Naoto Usuyama, Xu, Hanwen, Jaspreet Bagga, Robert Tinn, Sam Preston, Rajesh P. N. Rao, Wei Mu, Naveen Valluri, Cliff Wong, Tupini, Andrea, Wang, Yu, Mazzola, Matt, Shukla, Swadheen, Liden, Lars, Gao, Jianfeng, Crabtree, Angela, Piening, Brian, Bifulco, Carlo, Matthew P. Lungren, Tristan Naumann, Wang, Sheng, Hoifung Poon - arXiv (Cornell University), CoRR 2023 被引用: 544

  2. TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors

    著者: Na Tang, Chen Cheng, Xingying Zhang, Miaomiao Qiao, Na Li, Wei Mu, Xiao-Fei Wei, Weidong Han, Haoyi Wang - JCI Insight 2020 被引用: 390

  3. Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

    著者: Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang, Wei-Zhu Yang, Guowen Yin, Bin‐Yan Zhong, Junhui Sun, Zhi‐Cheng Jin, Jian-Jia Chen, Naijian Ge, Wen‐Bin Ding, Wenhui Li, Jinhua Huang, Wei Mu, Shanzhi Gu, Jiaping Li, Hui Zhao, Shu-Wei Wen, Yanming Lei, Yusheng Song, Chunwang Yuan, Weidong Wang, Ming Huang, Wei Zhao, Jianbing Wu, Song Wang, Xu Zhu, Jianjun Han, Weixin Ren, Zaiming Lu, Wenge Xing, Yong Fan, Hailan Lin, Zishu Zhang, Guohui Xu, Wenhao Hu, Qiang Tu, Hongying Su, Chuansheng Zheng, Yong Chen, Xuya Zhao, Zhu-ting Fang, Qi Wang, Qi Wang, Aibing Xu, Jian Xu, Qinghua Wu, Huanzhang Niu, Jian Wang, Feng Dai, Feng Dai, Qingdong Li, Rong-Shu Shi, Jiarui Li, Guang Yang, Hai‐Bin Shi, Jiansong Ji, Yue Liu, Zheng Cai, Po Song Yang, Yang Zhao, Xiaoli Zhu, Ligong Lu, Gao‐Jun Teng, Li-Gong Lu, Gao‐Jun Teng, for the CHANCE001 Investigators - Signal Transduction and Targeted Therapy 2023 被引用: 283

  4. Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications

    著者: Liyuan Cao, Wei Mu - Pharmacological Research 2020 被引用: 253

  5. Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images

    著者: Wei Mu, Lei Jiang, Yu Shi, Ilke Tunali, Jhanelle E Gray, Evangelia Katsoulakis, Jie Tian, Robert J. Gillies, Matthew B. Schabath - Journal for ImmunoTherapy of Cancer 2021 被引用: 205

  6. Non-invasive decision support for NSCLC treatment using PET/CT radiomics

    著者: Wei Mu, Lei Jiang, Jianyuan Zhang, Yu Shi, Jhanelle E. Gray, Ilke Tunali, Chao Gao, Yingying Sun, Jie Tian, Xinming Zhao, Xilin Sun, Robert J. Gillies, Matthew B. Schabath - Nature Communications 2020 被引用: 296

  7. Advances in Universal CAR-T Cell Therapy

    著者: Haolong Lin, Jiali Cheng, Wei Mu, Jianfeng Zhou, Li Zhu - Frontiers in Immunology 2021 被引用: 198

  8. Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats

    著者: Sandy Napel, Wei Mu, Bruna V. Jardim‐Perassi, Hugo J.W.L. Aerts, Robert J. Gillies - Cancer 2018 被引用: 215

  9. Training Small Multimodal Models to Bridge Biomedical Competency Gap: A Case Study in Radiology Imaging

    著者: Juan Manuel Zambrano Chaves, Shih-Cheng Huang, Yanbo Xu, Hanwen Xu, Naoto Usuyama, Sheng Zhang, Fei Wang, Yujia Xie, Mahmoud Khademi, Ziyi Yang, Hany Awadalla, Julia Gong, Houdong Hu, Jianwei Yang, Chunyuan Li, Jianfeng Gao, Yu Gu, Cliff Wong, Wei Mu, Tristan Naumann, Muhao Chen, Matthew P. Lungren, Chaudhari, Akshay, Serena Yeung, Curtis P. Langlotz, Sheng Wang, Hoifung Poon - arXiv (Cornell University), CoRR 2024 被引用: 36

  10. Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images

    著者: Panwen Tian, Bingxi He, Wei Mu, Kunqin Liu, Li Liu, Hao Zeng, Yujie Liu, Lili Jiang, Ping Zhou, Zhipei Huang, Di Dong, Weimin Li - Theranostics 2020 被引用: 151

  11. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway

    著者: Xiang Li, Shaomin Wang, Wei Mu, Jennifer Barry, Anna Han, Richard L. Carpenter, Bing‐Hua Jiang, Stephen C. Peiper, Mỹ G. Mahoney, Andrew E. Aplin, Hong Ren, Jun He - Journal of Experimental & Clinical Cancer Research 2022 被引用: 100

  12. Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

    著者: Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu, Xu-Hua Duan, Yujing Xin, Bin‐Yan Zhong, Jinzhang Chen, Jun Tie, Kangshun Zhu, Lan Zhang, Ming Huang, Mingjian Piao, Xiao Li, Hai‐Bin Shi, Ruibao Liu, Aibing Xu, Fanpu Ji, Jianbing Wu, Guoliang Shao, H. Li, Mingsheng Huang, Zhiyi Peng, Jiansong Ji, Chunwang Yuan, Xiufeng Liu, Zhou-Chao Hu, Wei-Zhu Yang, Guowen Yin, Jinhua Huang, Naijian Ge, Xiaolong Qi, Yang Zhao, Jiawei Zhou, Guohui Xu, Qiang Tu, Hailan Lin, Yaojun Zhang, Hua Jiang, Haibo Shao, Yong-Jie Su, Tingsong Chen, Baoqi Shi, Xiang Zhou, Haitao Zhao, Hai‐Dong Zhu, Zhenggang Ren, Gao‐Jun Teng, Gao-Jun Teng, Gao-Jun Teng, Zhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, Xu-Hua Duan, Yu-Jing Xin, Bin-Yan Zhong, Jin-Zhang Chen, Jun Tie, Kang-Shun Zhu, Lan Zhang, Ming Huang, Ming-Jian Piao, Xiao Li, Hai-Bin Shi, Rui-Bao Liu, Ai-Bing Xu, Fan-Pu Ji, Jian-Bing Wu, Guo-Liang Shao, Hai-Liang Li, Ming-Sheng Huang, Zhi-Yi Peng, Jian-Song Ji, Chun-Wang Yuan, Xiu-Feng Liu, Zhou-Chao Hu, Wei-Zhu Yang, Guo-Wen Yin, Jin-Hua Huang, Nai-Jian Ge, Xiao-Long Qi, Yang Zhao, Jia-Wei Zhou, Guo-Hui Xu, Qiang Tu, Hai-Lan Lin, Yao-Jun Zhang, Hua Jiang, Hai-Bo Shao, Yong-Jie Su, Ting-Song Chen, Bao-Qi Shi, Wen-Ge Xing, Shan-Zhi Gu, Wei-Dong Wang, Song Wang, Shu-Wei Wen, Wei-Fu Lv, Xu Zhu, Wei Mu, Wei-Xin Ren ほか 29 名 - EClinicalMedicine 2024 被引用: 143

  13. Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy

    著者: Wei Mu, Ilke Tunali, Jhanelle E. Gray, Jin Qi, Matthew B. Schabath, Robert J. Gillies - European Journal of Nuclear Medicine and Molecular Imaging 2019 被引用: 184

  14. Hyperuricemia induces endothelial dysfunction

    著者: Uday M. Khosla, Sergey Zharikov, Jennifer Finch, Takahiko Nakagawa, Carmen Roncal, Wei Mu, Karina Krotova, Edward R. Block, Sharma Prabhakar, Richard J. Johnson - Kidney International 2005 被引用: 1,205

  15. T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape

    著者: Zhenyu Dai, Wei Mu, Ya Zhao, Jiali Cheng, Haolong Lin, Kedong Ouyang, Xiangyin Jia, Jianwei Liu, Qiaoe Wei, Meng Wang, Chaohong Liu, Taochao Tan, Jianfeng Zhou - Signal Transduction and Targeted Therapy 2022 被引用: 82

  16. CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells

    著者: Yongping Zhang, Xingying Zhang, Chen Cheng, Wei Mu, Xiaojuan Liu, Na Li, Xiaofei Wei, Xiang Liu, Chang‐Qing Xia, Haoyi Wang - Frontiers of Medicine 2017 被引用: 231

  17. Macrophage accumulation in human progressive diabetic nephropathy

    著者: Duy T. Nguyen, Ping Fu, Wei Mu, Prudence A. Hill, Robert C. Atkins, Steven J. Chadban - Nephrology 2006 被引用: 338

  18. The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains

    著者: Zhenyu Dai, Wei Mu, Ya Zhao, Xiangyin Jia, Jianwei Liu, Qiaoe Wei, Taochao Tan, Jianfeng Zhou - Molecular Therapy 2021 被引用: 62

  19. Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study

    著者: Qiuhe Wang, Dongdong Xia, Wei Bai, Enxin Wang, Junhui Sun, Ming Huang, Wei Mu, Guowen Yin, H. Li, Hui Zhao, Jing Li, Chunqing Zhang, Xiaoli Zhu, Jianbing Wu, Jiaping Li, Weidong Gong, Zixiang Li, Zhengyu Lin, Xingnan Pan, Hai‐Bin Shi, Guoliang Shao, Jueshi Liu, Shufa Yang, Yanbo Zheng, Jian Xu, Jinlong Song, Wenhui Wang, Zhexuan Wang, Yuelin Zhang, Rong Ding, Hui Zhang, Hui Yu, Zheng Lin, Weiwei Gu, Nan You, Guangchuan Wang, Shuai Zhang, Long Feng, Lin Liu, Peng Zhang, Xueda Li, Jian Chen, Tao Xu, Wei-Zhong Zhou, Hui Zeng, Yongjin Zhang, Wukui Huang, Wenjin Jiang, Wen Zhang, Wenbo Shao, Lei Li, Jing Niu, Jie Yuan, Xiaomei Li, Yong Lv, Kai Li, Zhanxin Yin, Jielai Xia, Daiming Fan, Guohong Han - Journal of Hepatology 2019 被引用: 266

  20. Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies

    著者: Haolong Lin, Xiuxiu Yang, Shanwei Ye, Liang Huang, Wei Mu - Biomedicine & Pharmacotherapy 2024 被引用: 90

  21. FSE-Net: Rethinking the up-sampling operation in encoder-decoder structure for retinal vessel segmentation

    著者: Jiajia Ni, Wei Mu, An Pan, Zhengming Chen - Biomedical Signal Processing and Control, Biomed. Signal Process. Control. 2023 被引用: 29

  22. Images Are Data: Challenges and Opportunities in the Clinical Translation of Radiomics

    著者: Wei Mu, Matthew B. Schabath, Robert J. Gillies - Cancer Research 2022 被引用: 57

  23. Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis

    著者: Yunchun Zhou, Wei Mu, Jihua Zhang, Shi Wu Wen, Smita Pakhalé - BMJ Open 2022 被引用: 75

  24. A Global Building Occupant Behavior Database

    著者: Bing Dong, Yapan Liu, Wei Mu, Zixin Jiang, Pratik Pandey, Tianzhen Hong, Bjarne W. Olesen, Thomas Lawrence, Zheng O’Neil, Clinton J. Andrews, Elie Azar, Karol Bandurski, Ronita Bardhan, Mateus Bavaresco, Christiane Berger, Jane Burry, Salvatore Carlucci, Karin Maria Soares Chvatal, Marilena De Simone, Silvia Erba, Nan Gao, Lindsay T. Graham, Camila Grassi, Rishee K. Jain, Sanjay Kumar, Mikkel Baun Kjærgaard, Sepideh Sadat Korsavi, Jared Langevin, Zhengrong Li, Aleksandra Lipczyńska, Ardeshir Mahdavi, Jeetika Malik, Max Marschall, Zoltán Nagy, Letícia de Oliveira Neves, William O’Brien, Song Pan, June Young Park, Ilaria Pigliautile, Cristina Piselli, Anna Laura Pisello, Hamed Nabizadeh Rafsanjani, Ricardo Forgiarini Rupp, Flora D. Salim, Stefano Schiavon, Jens Hjort Schwee, Andrew Sonta, Marianne F. Touchie, Andreas Wagner, Sinéad Walsh, Zhe Wang, David M. Webber, Da Yan, Paolo Zangheri, Jingsi Zhang, Xiang Zhou, Xin Zhou - Scientific Data 2022 被引用: 89